New approaches to treatment of various cancers based on cytotoxic analogs of LHRH, somatostatin and bombesin.
about
Prostate cancer relevant antigens and enzymes for targeted drug deliveryPeptidic tumor targeting agents: the road from phage display peptide selections to clinical applications.Peptide targeting of platinum anti-cancer drugsAEZS-108 : a targeted cytotoxic analog of LHRH for the treatment of cancers positive for LHRH receptors.Enhanced anti-tumoral activity of methotrexate-human serum albumin conjugated nanoparticles by targeting with Luteinizing Hormone-Releasing Hormone (LHRH) peptide.Targeted cancer therapy with gonadotropin-releasing hormone chimeric proteins.Targeting of cytotoxic luteinizing hormone-releasing hormone analogs to breast, ovarian, endometrial, and prostate cancers.Issues related to targeted delivery of proteins and peptides.Luteinizing hormone-releasing hormone antagonists.Receptor-mediated tumor targeting based on peptide hormones.Novel LHRH-receptor-targeted cytolytic peptide, EP-100: first-in-human phase I study in patients with advanced LHRH-receptor-expressing solid tumors.Luteinizing hormone-releasing hormone receptor targeted agents for prostate cancer.Possibilities to increase the effectiveness of doxorubicin in cancer cells killing.Targeted chemotherapy of endometrial, ovarian and breast cancers with cytotoxic analogs of luteinizing hormone-releasing hormone (LHRH).Evaluation of the Biological Properties and the Enzymatic Stability of Glycosylated Luteinizing Hormone-Releasing Hormone AnalogsComparative in vitro biological evaluation of daunorubicin containing GnRH-I and GnRH-II conjugates developed for tumor targeting.Receptors for luteinizing hormone-releasing hormone (GnRH) as therapeutic targets in triple negative breast cancers (TNBC).Suppression of the proliferation of human U-87 MG glioblastoma cells by new antagonists of growth hormone-releasing hormone in vivo and in vitro.Goserelin loaded nanoparticles inhibit growth and induce apoptosis in human prostate cancer cell lines.Investigation of cancer cell lines for peptide receptor-targeted drug development.Application of human pancreatic carcinoid BON cells for receptor-targeted drug development.In vitro degradation and antitumor activity of oxime bond-linked daunorubicin-GnRH-III bioconjugates and DNA-binding properties of daunorubicin-amino acid metabolites.Gonadotropin-releasing hormone receptor-targeted paclitaxel-degarelix conjugate: synthesis and in vitro evaluation.Development of high affinity camptothecin-bombesin conjugates that have targeted cytotoxicity for bombesin receptor-containing tumor cells.Recent Development of Non-Peptide GnRH Antagonists.
P2860
Q27013843-48924067-A2C2-4F79-953A-73D28C414EB2Q33520512-90CEC46A-366D-44BF-93AA-5DFA37608C8BQ33937941-59648546-AE1F-4A75-A2D5-FDB91F57204BQ34274245-9646BB2B-8E7B-439D-ADD2-DA794DC03CDDQ35162175-1AF2F787-91F9-4761-9D48-7965A965EC12Q35641242-57B9F1FB-71BF-4CC4-813A-0D7887BB7F60Q36202016-141732D1-ED93-4FDD-9644-ECE5E6A1CC5EQ36616311-C0DFEEE0-03EA-4DE8-B70C-45DF39B64225Q37638747-DC691139-CB2C-4F08-B57D-24C49CC6F705Q37641368-576409A5-6E1D-44C6-B760-B515E9A9DCEDQ37724516-B47BA182-FABA-45A7-90C4-E7201AAB8255Q37859389-0B04E02B-3BD2-4DA9-9A69-E58E5C356F67Q37937579-F839A89B-37D3-446B-ADA0-DDBEFC5FA2D9Q38007373-FF0BEBE2-3EA3-4D96-97B4-6A7658630589Q38877441-10B41898-C846-4273-BB28-DFE0630B8DFFQ38882916-672C59DE-77F7-4787-8146-1A9401D10B7AQ38949880-03B80E4A-202B-4C8F-93EC-E7DB5CBFC471Q39201247-45DE38E5-7F82-428C-B396-06F433FE33FCQ39305979-8EB3789D-4A03-416C-8DCC-A6ACEB8BA544Q39492350-1A82D85D-68E7-4172-B94E-02B77652D835Q39630765-6BCFCD38-EE94-434C-86C1-76070073F646Q39643108-2B6FC2AB-4271-4F8C-ADC7-132FCEB965E8Q42828662-C1BE7CB5-9100-432E-8FB6-209AC08578A1Q44797073-39560652-D075-4A9A-9A08-BCB47D76E7C6Q47323557-8855AFF7-B2A5-4452-8578-E796C897A339
P2860
New approaches to treatment of various cancers based on cytotoxic analogs of LHRH, somatostatin and bombesin.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
New approaches to treatment of ...... RH, somatostatin and bombesin.
@ast
New approaches to treatment of ...... RH, somatostatin and bombesin.
@en
type
label
New approaches to treatment of ...... RH, somatostatin and bombesin.
@ast
New approaches to treatment of ...... RH, somatostatin and bombesin.
@en
prefLabel
New approaches to treatment of ...... RH, somatostatin and bombesin.
@ast
New approaches to treatment of ...... RH, somatostatin and bombesin.
@en
P1433
P1476
New approaches to treatment of ...... RH, somatostatin and bombesin.
@en
P2093
Attila Nagy
P304
P356
10.1016/S0024-3205(03)00113-9
P407
P577
2003-04-01T00:00:00Z